StonvexLoading…
StonvexStonvexStonvexCore line items from CF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.99B | $7.08B | $5.21B | $3.55B |
Operating Income | $863.00M | $2.30B | $1.68B | $1.10B |
Net Income | $676.00M | $1.80B | $1.30B | $843.00M |
EPS (Diluted) | $3.98 | $8.97 | $6.39 | $4.20 |
Total Assets | $14.61B | $14.09B | $14.20B | $13.75B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.04B | $1.98B | $1.84B | $1.69B |
Free Cash Flow OCF − CapEx | $273.00M | $1.80B | $1.49B | $772.00M |
Shares Outstanding | 154.50M | 153.55M | 164.30M | 165.90M |